查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1612894

细胞冷冻介质市场：按类型、应用和最终用途划分 - 2025-2030 年全球预测

Cell Freezing Media Market by Type (Dimethyl Sulfoxide-based Media, Glycerol-Based Media, Serum-Free Media), Application (Biobanking, Cancer Research, Genetic Engineering & CRISPR Technology), End-Use - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 196 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年细胞冷冻介质市场价值为1.8571亿美元，预计到2024年将达到2.0166亿美元，复合年增长率为8.71%，到2030年将达到3.3325亿美元。

细胞冷冻介质是一种用于冷冻保存的专用溶液，透过保护细胞在冷冻和解冻过程中免受损​​伤，在维持细胞活力和功能方面发挥重要作用。细胞冷冻介质的需求源自于多种领域的应用，包括生物样本库、再生医学、製药和学术研究。其最终用途范围广泛，涵盖专注于保存脆弱细胞株、干细胞和其他生物材料的医疗设施、实验室和生物技术公司。生物医学研究投资的增加、再生医学的进步以及对生技药品的需求不断增长推动了市场成长，这些都刺激了对创新保存方法的需求。生物技术研发基础设施不断扩大的新兴市场以及开发环保、无血清配方的机会比比皆是，这些配方可以最大限度地减少污染和过敏反应的风险，同时促进永续性。关键的成长要素包括技术进步、对个人化医疗的日益关注以及对干细胞疗法不断增长的需求，这些因素正在推动有效冷冻保存策略的采用。该市场面临的挑战包括先进冷冻介质的高成本以及与解冻后维持细胞活力相关的技术挑战。此外，监管限制和严格的品管标准可能会阻碍市场的快速扩张。为了缓解这些挑战，公司应专注于开发符合行业标准的经济高效且高效的替代方案。创新领域包括增强冷冻保护剂配方以提高细胞回收率、整合自动化冷冻保存系统以及开发新型添加剂以改善更广泛细胞类型的保存。策略性成长也应考虑与学术和研究机构合作，推动创新并投资于市场教育，以提高对先进冷冻保存解决方案的好处和应用的认识。总体而言，细胞冷冻介质市场代表着一个充满活力的机会，但需要克服某些技术和成本障碍才能充分发挥其潜力。

主要市场统计
基准年[2023] 1.8571 亿美元
预测年份 [2024] 20166万美元
预测年份 [2030] 33325万美元
复合年增长率（%） 8.71%

市场动态：揭示快速发展的细胞冷冻介质市场的关键市场洞察

供需的动态交互作用正在改变细胞冷冻培养基市场。了解这些不断变化的市场动态可以帮助企业做出明智的投资决策、策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，同时消费行为及其对製造成本的影响以及对采购趋势的影响。

  • 市场驱动因素
    • 对先进生物製药的需求迅速增长以及生物银行活动的相应增长
    • 增加对基于细胞培养的疫苗的投资
    • 生物製药製造中对一次性技术的偏好日益增长
  • 市场限制因素
    • 与细胞生物学研究相关的高成本
  • 市场机会
    • 再生医学的进步和对高品质冷冻保存技术的需求
    • 人工智慧、物联网等先进技术在培养基超低温保存的融合
  • 市场挑战
    • 核准和使用细胞冷冻介质的严格监管要求

波特的五力：驾驭细胞冷冻培养基市场的策略工具

波特的五力框架是了解细胞冷冻介质市场竞争格局的关键工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解细胞冷冻介质市场的外部影响

外部宏观环境因素在塑造细胞冷冻介质市场的绩效动态方面发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并为他们做出积极主动的决策做好准备。

市场占有率分析 了解细胞冷冻介质市场的竞争格局

对细胞冷冻介质市场的详细市场占有率分析可以对供应商的绩效进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV 定位基质细胞冷冻介质市场供应商的绩效评估

FPNV定位矩阵是评估细胞冷冻介质市场供应商的重要工具。此矩阵允许业务组织根据商务策略和产品满意度评估供应商，从而做出与其目标相符的明智决策。这四个象限使您能够清晰、准确地划分供应商，并确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析和建议描绘了细胞冷冻介质市场的成功之路

对于旨在加强在全球市场的影响力的公司来说，细胞冷冻介质市场的策略分析至关重要。透过审查关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机并取得长期成功。

本报告对市场进行了全面分析，涵盖关键重点领域：

1. 市场渗透率：对当前市场环境的详细审查、主要企业的广泛资料、对其在市场中的影响力和整体影响力的评估。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 对先进生物製药的需求不断增加以及生物银行活动的相应增长
      • 增加对细胞培养疫苗的投资
      • 生物製药製造中对一次性技术的日益青睐
    • 抑制因素
      • 与细胞生物学研究相关的高成本
    • 机会
      • 再生医学的进步和对高品质冷冻保存技术的需求
      • 人工智慧、物联网等先进技术在培养基超低温保存的融合
    • 任务
      • 核准和使用细胞冷冻介质的严格监管要求
  • 市场区隔分析
    • 类型：在复杂皮肤病的生物製药配方中使用甘油基载体
    • 最终用途：製药和生物技术公司越来越多地使用细胞冷冻介质进行药物发现和开发
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章细胞冷冻介质市场：依类型

  • 二甲基亚砜介质
  • 甘油基培养基
  • 无血清培养基

第七章细胞冷冻介质市场：依应用

  • 生物银行
  • 癌症研究
  • 基因工程和CRISPR技术
  • 医药研发
  • 再生医学
  • 疫苗开发

第 8 章细胞冷冻介质市场：依最终用途分类

  • 製药和生物技术公司
  • 调查机构

第九章美洲细胞冷冻培养基市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第10章亚太细胞冷冻培养基市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十一章欧洲、中东和非洲细胞冷冻培养基市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十二章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
    • 赛多利斯完成对 Polyplus 的收购
    • Qkine 和 Sartorius 合作创建了用于分析高级细胞模型的完整工作流程解决方案
    • ExCell Bio 在乌拉圭开设新工厂
  • 战略分析和建议

公司名单

  • Abcam Limited
  • AMSBIO, Inc.
  • Bio-Rad Laboratories, Inc.
  • Bio-Techne Corporation
  • BPS Bioscience, Inc.
  • Capricorn Scientific
  • Carl Roth GmbH+Co. KG
  • Celprogen Corporation
  • Charles River Laboratories
  • Elabscience Bionovation Inc.
  • ExCell Biotechnology Co., Ltd
  • Funakoshi Co., Ltd.
  • HiMedia Laboratories
  • Merck KGaA
  • NIPPON Genetics EUROPE GmbH
  • PAN-Biotech GmbH
  • PromoCell GmbH
  • Qiagen NV
  • Sartorius AG
  • STEMCELL Technologies
  • Thermo Fisher Scientific Inc.
  • WELGENE Inc.
Product Code: MRR-3F223D524794

The Cell Freezing Media Market was valued at USD 185.71 million in 2023, expected to reach USD 201.66 million in 2024, and is projected to grow at a CAGR of 8.71%, to USD 333.25 million by 2030.

Cell freezing media, a specialized solution used in cryopreservation, plays a critical role in preserving the viability and functionality of cells by protecting them from damage during the freezing and thawing processes. The necessity for cell freezing media stems from its application across various fields including biobanking, regenerative medicine, pharmaceuticals, and academic research. Its end-use scope is vast, encompassing medical facilities, research laboratories, and biotech firms focusing on storing delicate cell lines, stem cells, and other biological materials. Market growth is driven by increased investments in biomedical research, advancements in regenerative medicine, and the growing need for biologics, which are fueling demand for innovative preservation methods. Opportunities are abundant in emerging markets where biotechnology R&D infrastructure is being expanded, as well as in developing eco-friendly and serum-free formulations that minimize risk of contamination and allergic reactions while promoting sustainability. Key growth influencers include technological advancements, a rising focus on personalized medicine, and increasing demand for stem cell therapies, which promote the adoption of effective cryopreservation strategies. Limitations in the market include the high cost of advanced freezing media and the technical challenges associated with maintaining cell viability post-thawing. Moreover, regulatory constraints and stringent quality control standards may hinder rapid market expansion. To mitigate such challenges, companies should focus on developing cost-effective and efficient alternatives that conform to industry standards. Areas of innovation include enhancing cryoprotectant formulations for better cell recovery rates, integrating automated cryopreservation systems, and developing novel additives that improve preservation of a wider range of cell types. For strategic growth, businesses should also consider collaborations with academic and research institutions to drive innovation, as well as investing in market education to boost awareness about the benefits and applications of advanced cryopreservation solutions. Overall, the cell freezing media market exhibits dynamic opportunities, yet requires overcoming certain technical and cost barriers to fully realize its potential.

KEY MARKET STATISTICS
Base Year [2023] USD 185.71 million
Estimated Year [2024] USD 201.66 million
Forecast Year [2030] USD 333.25 million
CAGR (%) 8.71%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Cell Freezing Media Market

The Cell Freezing Media Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • The surging demand for advanced biopharmaceuticals and the consequent growth in biobanking activities
    • Increasing investment in cell culture-based vaccines
    • Growing preference for single-use technologies in biopharmaceutical production
  • Market Restraints
    • High cost associated with cell biology research
  • Market Opportunities
    • Advancements in regenerative medicine and the need for high-quality cryopreservation techniques
    • Integration of advanced technologies such as AI and IoT in media cryopreservation
  • Market Challenges
    • Strict regulatory requirements for the approval and use of cell freezing media

Porter's Five Forces: A Strategic Tool for Navigating the Cell Freezing Media Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Cell Freezing Media Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Cell Freezing Media Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Cell Freezing Media Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Cell Freezing Media Market

A detailed market share analysis in the Cell Freezing Media Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Cell Freezing Media Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Cell Freezing Media Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Cell Freezing Media Market

A strategic analysis of the Cell Freezing Media Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Cell Freezing Media Market, highlighting leading vendors and their innovative profiles. These include Abcam Limited, AMSBIO, Inc., Bio-Rad Laboratories, Inc., Bio-Techne Corporation, BPS Bioscience, Inc., Capricorn Scientific, Carl Roth GmbH + Co. KG, Celprogen Corporation, Charles River Laboratories, Elabscience Bionovation Inc., ExCell Biotechnology Co., Ltd, Funakoshi Co., Ltd., HiMedia Laboratories, Merck KGaA, NIPPON Genetics EUROPE GmbH, PAN-Biotech GmbH, PromoCell GmbH, Qiagen NV, Sartorius AG, STEMCELL Technologies, Thermo Fisher Scientific Inc., and WELGENE Inc..

Market Segmentation & Coverage

This research report categorizes the Cell Freezing Media Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Type, market is studied across Dimethyl Sulfoxide-based Media, Glycerol-Based Media, and Serum-Free Media.
  • Based on Application, market is studied across Biobanking, Cancer Research, Genetic Engineering & CRISPR Technology, Pharmaceutical Research & Development, Regenerative Medicine, and Vaccine Development.
  • Based on End-Use, market is studied across Pharmaceutical & Biotechnology Companies and Research Institutes.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. The surging demand for advanced biopharmaceuticals and the consequent growth in biobanking activities
      • 5.1.1.2. Increasing investment in cell culture-based vaccines
      • 5.1.1.3. Growing preference for single-use technologies in biopharmaceutical production
    • 5.1.2. Restraints
      • 5.1.2.1. High cost associated with cell biology research
    • 5.1.3. Opportunities
      • 5.1.3.1. Advancements in regenerative medicine and the need for high-quality cryopreservation techniques
      • 5.1.3.2. Integration of advanced technologies such as AI and IoT in media cryopreservation
    • 5.1.4. Challenges
      • 5.1.4.1. Strict regulatory requirements for the approval and use of cell freezing media
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Type: Utilization of Glycerol-based media in biopharmaceutical formulations to cater to sophisticated skin conditions
    • 5.2.2. End-Use: Increasing usage of cell freezing media in pharmaceuticals and biotechnology firms for novel drug discovery and development
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Cell Freezing Media Market, by Type

  • 6.1. Introduction
  • 6.2. Dimethyl Sulfoxide-based Media
  • 6.3. Glycerol-Based Media
  • 6.4. Serum-Free Media

7. Cell Freezing Media Market, by Application

  • 7.1. Introduction
  • 7.2. Biobanking
  • 7.3. Cancer Research
  • 7.4. Genetic Engineering & CRISPR Technology
  • 7.5. Pharmaceutical Research & Development
  • 7.6. Regenerative Medicine
  • 7.7. Vaccine Development

8. Cell Freezing Media Market, by End-Use

  • 8.1. Introduction
  • 8.2. Pharmaceutical & Biotechnology Companies
  • 8.3. Research Institutes

9. Americas Cell Freezing Media Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Cell Freezing Media Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Cell Freezing Media Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
    • 12.3.1. Sartorius completes acquisition of Polyplus
    • 12.3.2. Qkine and Sartorius Partnership Delivers a Complete Workflow Solution for the Analysis of Advanced Cell Models
    • 12.3.3. ExCell Bio Launches a New Factory in Uruguay
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Abcam Limited
  • 2. AMSBIO, Inc.
  • 3. Bio-Rad Laboratories, Inc.
  • 4. Bio-Techne Corporation
  • 5. BPS Bioscience, Inc.
  • 6. Capricorn Scientific
  • 7. Carl Roth GmbH + Co. KG
  • 8. Celprogen Corporation
  • 9. Charles River Laboratories
  • 10. Elabscience Bionovation Inc.
  • 11. ExCell Biotechnology Co., Ltd
  • 12. Funakoshi Co., Ltd.
  • 13. HiMedia Laboratories
  • 14. Merck KGaA
  • 15. NIPPON Genetics EUROPE GmbH
  • 16. PAN-Biotech GmbH
  • 17. PromoCell GmbH
  • 18. Qiagen NV
  • 19. Sartorius AG
  • 20. STEMCELL Technologies
  • 21. Thermo Fisher Scientific Inc.
  • 22. WELGENE Inc.

LIST OF FIGURES

  • FIGURE 1. CELL FREEZING MEDIA MARKET RESEARCH PROCESS
  • FIGURE 2. CELL FREEZING MEDIA MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL CELL FREEZING MEDIA MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL CELL FREEZING MEDIA MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL CELL FREEZING MEDIA MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL CELL FREEZING MEDIA MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL CELL FREEZING MEDIA MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL CELL FREEZING MEDIA MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL CELL FREEZING MEDIA MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL CELL FREEZING MEDIA MARKET SIZE, BY END-USE, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL CELL FREEZING MEDIA MARKET SIZE, BY END-USE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS CELL FREEZING MEDIA MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 13. AMERICAS CELL FREEZING MEDIA MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. UNITED STATES CELL FREEZING MEDIA MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 15. UNITED STATES CELL FREEZING MEDIA MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC CELL FREEZING MEDIA MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. ASIA-PACIFIC CELL FREEZING MEDIA MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA CELL FREEZING MEDIA MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA CELL FREEZING MEDIA MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. CELL FREEZING MEDIA MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 21. CELL FREEZING MEDIA MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. CELL FREEZING MEDIA MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL CELL FREEZING MEDIA MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL CELL FREEZING MEDIA MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL CELL FREEZING MEDIA MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. CELL FREEZING MEDIA MARKET DYNAMICS
  • TABLE 7. GLOBAL CELL FREEZING MEDIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL CELL FREEZING MEDIA MARKET SIZE, BY DIMETHYL SULFOXIDE-BASED MEDIA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL CELL FREEZING MEDIA MARKET SIZE, BY GLYCEROL-BASED MEDIA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL CELL FREEZING MEDIA MARKET SIZE, BY SERUM-FREE MEDIA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL CELL FREEZING MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL CELL FREEZING MEDIA MARKET SIZE, BY BIOBANKING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL CELL FREEZING MEDIA MARKET SIZE, BY CANCER RESEARCH, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL CELL FREEZING MEDIA MARKET SIZE, BY GENETIC ENGINEERING & CRISPR TECHNOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL CELL FREEZING MEDIA MARKET SIZE, BY PHARMACEUTICAL RESEARCH & DEVELOPMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL CELL FREEZING MEDIA MARKET SIZE, BY REGENERATIVE MEDICINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL CELL FREEZING MEDIA MARKET SIZE, BY VACCINE DEVELOPMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL CELL FREEZING MEDIA MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL CELL FREEZING MEDIA MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL CELL FREEZING MEDIA MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. AMERICAS CELL FREEZING MEDIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 22. AMERICAS CELL FREEZING MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 23. AMERICAS CELL FREEZING MEDIA MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 24. AMERICAS CELL FREEZING MEDIA MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 25. ARGENTINA CELL FREEZING MEDIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 26. ARGENTINA CELL FREEZING MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 27. ARGENTINA CELL FREEZING MEDIA MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 28. BRAZIL CELL FREEZING MEDIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 29. BRAZIL CELL FREEZING MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 30. BRAZIL CELL FREEZING MEDIA MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 31. CANADA CELL FREEZING MEDIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 32. CANADA CELL FREEZING MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 33. CANADA CELL FREEZING MEDIA MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 34. MEXICO CELL FREEZING MEDIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 35. MEXICO CELL FREEZING MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 36. MEXICO CELL FREEZING MEDIA MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 37. UNITED STATES CELL FREEZING MEDIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 38. UNITED STATES CELL FREEZING MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 39. UNITED STATES CELL FREEZING MEDIA MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 40. UNITED STATES CELL FREEZING MEDIA MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 41. ASIA-PACIFIC CELL FREEZING MEDIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 42. ASIA-PACIFIC CELL FREEZING MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 43. ASIA-PACIFIC CELL FREEZING MEDIA MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 44. ASIA-PACIFIC CELL FREEZING MEDIA MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 45. AUSTRALIA CELL FREEZING MEDIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 46. AUSTRALIA CELL FREEZING MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 47. AUSTRALIA CELL FREEZING MEDIA MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 48. CHINA CELL FREEZING MEDIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 49. CHINA CELL FREEZING MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 50. CHINA CELL FREEZING MEDIA MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 51. INDIA CELL FREEZING MEDIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 52. INDIA CELL FREEZING MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 53. INDIA CELL FREEZING MEDIA MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 54. INDONESIA CELL FREEZING MEDIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 55. INDONESIA CELL FREEZING MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 56. INDONESIA CELL FREEZING MEDIA MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 57. JAPAN CELL FREEZING MEDIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 58. JAPAN CELL FREEZING MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 59. JAPAN CELL FREEZING MEDIA MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 60. MALAYSIA CELL FREEZING MEDIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 61. MALAYSIA CELL FREEZING MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 62. MALAYSIA CELL FREEZING MEDIA MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 63. PHILIPPINES CELL FREEZING MEDIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 64. PHILIPPINES CELL FREEZING MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 65. PHILIPPINES CELL FREEZING MEDIA MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 66. SINGAPORE CELL FREEZING MEDIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 67. SINGAPORE CELL FREEZING MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 68. SINGAPORE CELL FREEZING MEDIA MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 69. SOUTH KOREA CELL FREEZING MEDIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 70. SOUTH KOREA CELL FREEZING MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 71. SOUTH KOREA CELL FREEZING MEDIA MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 72. TAIWAN CELL FREEZING MEDIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 73. TAIWAN CELL FREEZING MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 74. TAIWAN CELL FREEZING MEDIA MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 75. THAILAND CELL FREEZING MEDIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 76. THAILAND CELL FREEZING MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 77. THAILAND CELL FREEZING MEDIA MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 78. VIETNAM CELL FREEZING MEDIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 79. VIETNAM CELL FREEZING MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 80. VIETNAM CELL FREEZING MEDIA MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 81. EUROPE, MIDDLE EAST & AFRICA CELL FREEZING MEDIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 82. EUROPE, MIDDLE EAST & AFRICA CELL FREEZING MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 83. EUROPE, MIDDLE EAST & AFRICA CELL FREEZING MEDIA MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 84. EUROPE, MIDDLE EAST & AFRICA CELL FREEZING MEDIA MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 85. DENMARK CELL FREEZING MEDIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 86. DENMARK CELL FREEZING MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 87. DENMARK CELL FREEZING MEDIA MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 88. EGYPT CELL FREEZING MEDIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 89. EGYPT CELL FREEZING MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 90. EGYPT CELL FREEZING MEDIA MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 91. FINLAND CELL FREEZING MEDIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 92. FINLAND CELL FREEZING MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 93. FINLAND CELL FREEZING MEDIA MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 94. FRANCE CELL FREEZING MEDIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 95. FRANCE CELL FREEZING MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 96. FRANCE CELL FREEZING MEDIA MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 97. GERMANY CELL FREEZING MEDIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 98. GERMANY CELL FREEZING MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 99. GERMANY CELL FREEZING MEDIA MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 100. ISRAEL CELL FREEZING MEDIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 101. ISRAEL CELL FREEZING MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 102. ISRAEL CELL FREEZING MEDIA MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 103. ITALY CELL FREEZING MEDIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 104. ITALY CELL FREEZING MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 105. ITALY CELL FREEZING MEDIA MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 106. NETHERLANDS CELL FREEZING MEDIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 107. NETHERLANDS CELL FREEZING MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 108. NETHERLANDS CELL FREEZING MEDIA MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 109. NIGERIA CELL FREEZING MEDIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 110. NIGERIA CELL FREEZING MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 111. NIGERIA CELL FREEZING MEDIA MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 112. NORWAY CELL FREEZING MEDIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 113. NORWAY CELL FREEZING MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 114. NORWAY CELL FREEZING MEDIA MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 115. POLAND CELL FREEZING MEDIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 116. POLAND CELL FREEZING MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 117. POLAND CELL FREEZING MEDIA MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 118. QATAR CELL FREEZING MEDIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 119. QATAR CELL FREEZING MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 120. QATAR CELL FREEZING MEDIA MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 121. RUSSIA CELL FREEZING MEDIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 122. RUSSIA CELL FREEZING MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 123. RUSSIA CELL FREEZING MEDIA MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 124. SAUDI ARABIA CELL FREEZING MEDIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 125. SAUDI ARABIA CELL FREEZING MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 126. SAUDI ARABIA CELL FREEZING MEDIA MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 127. SOUTH AFRICA CELL FREEZING MEDIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 128. SOUTH AFRICA CELL FREEZING MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 129. SOUTH AFRICA CELL FREEZING MEDIA MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 130. SPAIN CELL FREEZING MEDIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 131. SPAIN CELL FREEZING MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 132. SPAIN CELL FREEZING MEDIA MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 133. SWEDEN CELL FREEZING MEDIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 134. SWEDEN CELL FREEZING MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 135. SWEDEN CELL FREEZING MEDIA MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 136. SWITZERLAND CELL FREEZING MEDIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 137. SWITZERLAND CELL FREEZING MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 138. SWITZERLAND CELL FREEZING MEDIA MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 139. TURKEY CELL FREEZING MEDIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 140. TURKEY CELL FREEZING MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 141. TURKEY CELL FREEZING MEDIA MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 142. UNITED ARAB EMIRATES CELL FREEZING MEDIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 143. UNITED ARAB EMIRATES CELL FREEZING MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 144. UNITED ARAB EMIRATES CELL FREEZING MEDIA MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 145. UNITED KINGDOM CELL FREEZING MEDIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 146. UNITED KINGDOM CELL FREEZING MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 147. UNITED KINGDOM CELL FREEZING MEDIA MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 148. CELL FREEZING MEDIA MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 149. CELL FREEZING MEDIA MARKET, FPNV POSITIONING MATRIX, 2023